Landec Corporation Announces CEO Video Interview with Nasdaq

June 11, 2010
Landec Corporation Announces CEO Video Interview with Nasdaq

MENLO PARK, Calif., Jun 11, 2010 (BUSINESS WIRE) --Landec Corporation (Nasdaq:LNDC), a materials science company that develops and markets patented polymer products for food, agricultural, medical device and licensed partner applications, today announced that a new Nasdaq video interview with Gary Steele, Chairman and CEO of Landec, is now available for investors on the Landec Investor Relations webpage.

The Nasdaq CEO Signature Series interview was conducted on June 9, 2010 at Nasdaq MarketSite in New York City, and provides an overview of the Company's business, including the recent acquisition of Lifecore Biomedical announced on May 3, 2010.

The interview can be found on Landec's website at http://investor.shareholder.com/ceosignature/webcast.cfm?mediaid=42590&k=DC1ED4CA97D619A08173364F936D6DF3.

About Landec Corporation

Landec is a materials science company, leveraging its capability in polymer science and bio-application development in order to commercialize new products within a variety of life science fields, including food, agricultural, personal care and medical device applications. With its Intelimer® polymers, Landec is able to customize its proprietary polymer materials for each application through the manipulation of their unique controlled release, temperature activation and/or biocompatibility properties. Landec's subsidiary, Apio Inc., has leveraged Landec's BreatheWay® membrane to become the leader in US fresh-cut specialty vegetables. Landec Ag offers a full solution of seed coatings and enhancements that work with the latest genetic technologies to drive continuous improvements in crop yield. Landec has also commercialized dozens of personal care and adhesive products through its long-standing partner relationships. With its recent acquisition of Lifecore Biomedical, Landec is now a leading supplier of premium hyaluronan-based biomaterials for the medical and veterinary markets, as well as the leading supplier to ophthalmology companies. For more information about the Company visit Landec's website at http://investor.shareholder.com/ceosignature/webcast.cfm?mediaid=42590&k=DC1ED4CA97D619A08173364F936D6DF3.

SOURCE: Landec Corporation

At the Company:
Landec Corporation
Gregory S. Skinner, 650-261-3677
Vice President Finance and CFO
or
EAS & Associates:
Liz Saghi, 415-816-8868